Nubain and Dyskinesia - a phase IV clinical study of FDA data

Summary:

Dyskinesia is reported as a side effect among people who take Nubain (nalbuphine hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Versed, and have Back pain.

The phase IV clinical study analyzes which people have Dyskinesia when taking Nubain. It is created by eHealthMe based on reports of 1,718 people who have side effects when taking Nubain from the FDA, and is updated regularly.

What is Nubain?

Nubain has active ingredients of nalbuphine hydrochloride. It is often used in pain. eHealthMe is studying from 1,749 Nubain users. Check the latest studies of Nubain.

What is Dyskinesia?

Dyskinesia (abnormality or impairment of voluntary movement) is found to be associated with 1,511 drugs and 1,734 conditions by eHealthMe. Check the latest studies of Dyskinesia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

1,718 people reported to have side effects when taking Nubain.
Among them, 11 people (0.64%) have Dyskinesia.

Among these 11 people:

How long have people been on Nubain when they have Dyskinesia? *

What is the gender of people who have Dyskinesia when taking Nubain? *

female: 60 %
male: 40 %

What is the age of people who have Dyskinesia when taking Nubain? *

What are other drugs people take besides Nubain? *

What are other side effects people have besides Dyskinesia? *

Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 3 people, 27.27%
Agitation (state of anxiety or nervous excitement): 3 people, 27.27%
Nausea And Vomiting: 2 people, 18.18%
Fall: 2 people, 18.18%
Feeling Hot: 2 people, 18.18%
Diarrhea: 2 people, 18.18%
Delirium Tremens (a psychotic condition typical of withdrawal in chronic alcoholics): 2 people, 18.18%
Ligament Rupture (tear in ligament): 2 people, 18.18%
Confusional State: 2 people, 18.18%
Tendon Rupture (tear of tendon): 2 people, 18.18%

What are the existing conditions these people have? *

Stress And Anxiety: 3 people, 27.27%
Back Pain: 3 people, 27.27%
Sleep Disorder: 2 people, 18.18%
Muscle Spasms (muscle contraction): 2 people, 18.18%
Breakthrough Pain: 2 people, 18.18%
Sedation: 1 person, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Neuropathy Peripheral (surface nerve damage): 1 person, 9.09%
Migraine (headache): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Nubain and have Dyskinesia?

- Check whether Dyskinesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nubain:

Nubain (1,749 reports)

Dyskinesia treatments and more:

Dyskinesia (50,549 reports)

Browse all side effects of Nubain:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyskinesia:

Dyskinesia (1,511 drugs)

Browse all the conditions that are associated with Dyskinesia:

Dyskinesia (1,734 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nalbuphine hydrochloride (the active ingredients of Nubain) and Nubain (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.